Formycon mit Sitz in Martinsried bei München entwickelt biopharmazeutische Nachahmerprodukte für die Zulassung in Europa, USA und Japan. Biopharmazeutika (Antikörper) werden bei Krebs eingesetzt.
COMPANY
INVESTOR TERMSHEET
FYB
Formycon
#BGFL Mood:
Neutral
·
#BGFL-Indicator:
Hold
·
Review date:
-
LEI:
39120005TZ76GQOY8Z19
SECTOR:
Gesundheit
SUB-SECTOR:
Biotechnologie
Formycon
A1EWVY
DE000A1EWVY8
FYB
SDAX
Xetra
Headquarter Formycon: boersengefluester.de (BGFL) has always attached great importance to showing where the companies have their headquarters - in other words, where they are rooted regionally. We have therefore always linked the company address in our database to the map material from Google Maps using an exact plus code. .
Visualisation of financial information has been one of boersengefluester.de's (BGFL) favourite disciplines from the very beginning. For this reason, we also put a lot of effort into maintaining our own database and have developed numerous analysis tools and key figure tables on this basis.
The stock market doesn't always have to be about traditional key figures such as turnover, profit and dividends. We also find the apps we have created for regional social issues, media presences or even the visualisation of your own website extremely interesting. And our ‘share wheel of fortune’ has addictive potential anyway.
boersengefluester.de · #BGFL
· © 2024
The news manufactory
Good luck with all your investments
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
Idea & concept: 3R Technologies
boersengefluester.de GmbH
Copyright © 2024
by Gereon Kruse
#BGFL